Biblio
Export 239 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is B [Clear All Filters]
“Combinatorial Treatment Effects in a Cell Culture Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1155-1166, 2017.
, “Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures.”, J Alzheimers Dis, vol. 61, no. 1, pp. 389-399, 2018.
, “Histogram-Based Feature Extraction from Individual Gray Matter Similarity-Matrix for Alzheimer's Disease Classification.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1571-1582, 2017.
, “Classification of Alzheimer's Disease and Prediction of Mild Cognitive Impairment Conversion Using Histogram-Based Analysis of Patient-Specific Anatomical Brain Connectivity Networks.”, J Alzheimers Dis, vol. 60, no. 1, pp. 295-304, 2017.
, “Risk Assessment of Alzheimer's Disease using the Information Diffusion Model from Structural Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1335-42, 2016.
, “Monitoring Alzheimer's Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1493-150, 2022.
, “The Cognition and Flow Study: A Feasibility Randomized Controlled Trial of the Effects of Cognitive Training on Cerebral Blood Flow.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1567-1581, 2021.
, “Cerebral Hemodynamics in Mild Cognitive Impairment: A Systematic Review.”, J Alzheimers Dis, vol. 59, no. 1, pp. 369-385, 2017.
, “Anthocyanins Protect SK-N-SH Cells Against Acrolein-Induced Toxicity by Preserving the Cellular Redox State.”, J Alzheimers Dis, vol. 50, no. 4, pp. 981-98, 2016.
, “Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 2, pp. 615-631, 2017.
, “Acute Exercise and Cognitive Function in Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. 2, pp. 749-760, 2021.
, “Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.”, J Alzheimers Dis, vol. 62, no. 1, pp. 399-408, 2018.
, “An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.”, J Alzheimers Dis, vol. 60, no. 1, pp. 11-21, 2017.
, “Physical and Cognitive Stimulation Using an Exergame in Subjects with Normal Aging, Mild and Moderate Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1299-314, 2016.
, “Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain.”, J Alzheimers Dis, vol. 76, no. 1, pp. 33-40, 2020.
, “Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.”, J Alzheimers Dis, vol. 86, no. 1, pp. 83-109, 2022.
, “Purported Interactions of Amyloid-β and Glucocorticoids in Cytotoxicity and Genotoxicity: Implications in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1085-1094, 2016.
, “Performance on Specific Cognitive Domains and Cause of Death: A Prospective Population-Based Study in Non-Demented Older Adults (NEDICES).”, J Alzheimers Dis, vol. 51, no. 2, pp. 533-44, 2016.
, “Implication of Circulating Extracellular Vesicles-Bound Amyloid-β42 Oligomers in the Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 2, pp. 813-825, 2023.
, “Religious Orders Study and Rush Memory and Aging Project.”, J Alzheimers Dis, vol. 64, no. s1, pp. S161-S189, 2018.
, “Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1179-87, 2016.
, “Cognitive Event-Related Potential, an Early Diagnosis Biomarker in Frail Elderly Subjects: The ERP-MAPT-PLUS Ancillary Study.”, J Alzheimers Dis, vol. 58, no. 1, pp. 87-97, 2017.
, “Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1251-62, 2016.
, “Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People.”, J Alzheimers Dis, vol. 49, no. 2, pp. 387-98, 2016.
, “The level of 24-Hydroxycholesteryl Esters is an Early Marker of Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 2, pp. 825-833, 2017.
,